Nearly 15% of Prescribing U.S. Rheumatologists Use Scipher Medicine’s PrismRA Blood Test Since Its Launch A Year Ago

Dec 6, 2021

PrismRA enables precision medicine, supports better outcomes, and reduces ineffective utilization of TNFi therapy for rheumatoid arthritis treatment  WALTHAM, Mass. (December 6, 2021) – Scipher Medicine, a precision immunology company matching patients with their most...

America’s Choice Provider Network Partners with Scipher Medicine to Improve Patient Outcomes and Lower Costs for Rheumatoid Arthritis Care

Nov 30, 2021

Highlights:PrismRA® Blood Test Supports Personalized Treatment for RA PatientsImproves Clinical Outcomes for Rheumatoid Arthritis (RA) Patients. WALTHAM, Mass. (December 1, 2021) – Scipher Medicine, a precision immunology company matching patients with...

RxParadigm Partners with Scipher Medicine® to Support Medication Utilization, Improve Patient Outcomes, and Lower Costs for Rheumatoid Arthritis Care

Nov 15, 2021

November 15, 2021 – WALTHAM, Mass. – Scipher Medicine, a precision immunology company matching patients with their most effective medication therapies, today announced a partnership with RxParadigm, a pharmacy benefit manager company delivering...

Scipher Medicine^® to Present at the Jeffries London Healthcare Conference

Nov 11, 2021

November 11, 2021 – WALTHAM, Mass. – Scipher Medicine, a precision immunology company matching patients with their most effective therapies, today announced that Alif Saleh, Chief Executive Officer, and John Strumbos, Chief Financial Officer, will...

Scipher Medicine^® to Present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum

Nov 10, 2021

November 10, 2021  – WALTHAM, Mass. – Scipher Medicine, a precision immunology company matching patients with their most effective therapies, today announced that Alif Saleh, Chief Executive Officer, and John Strumbos, Chief Financial Officer will...

GNS Healthcare and Scipher Medicine® Collaborate to Develop World’s First in silico Patient for Rheumatoid Arthritis

Nov 4, 2021

– Partnership leverages Scipher Medicine’s proprietary patient clinico-genomic data – In silico patient models enable pharmaceutical companies to understand what disease treatments work for which patients and why SOMERVILLE, Mass. & WALTHAM,...